Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Declines By 58.3%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a large decrease in short interest in March. As of March 15th, there was short interest totalling 1,500 shares, a decrease of 58.3% from the February 28th total of 3,600 shares. Based on an average daily trading volume, of 66,600 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Stock Down 10.0 %

Shares of BriaCell Therapeutics stock traded down $0.01 during trading on Friday, reaching $0.09. 14,109 shares of the company traded hands, compared to its average volume of 102,936. BriaCell Therapeutics has a 1-year low of $0.07 and a 1-year high of $1.39. The company has a 50 day moving average price of $0.12 and a 200-day moving average price of $0.24.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.